Pulmonary Infections
From the Journals
Nebulized amphotericin B does not affect aspergillosis exacerbation-free status at 1 year
NAB may delay onset and incidence of aspergillosis exacerbations.
From the Journals
Comorbid respiratory disease key predictor of NTM-PD
Overall, comorbid respiratory disease was significantly associated with an increased risk of NTM-PD.
From the Journals
Proteomics reveals potential targets for drug-resistant TB
Apolipoproteins “may be involved in the pathogenesis of DR-TB by accelerating the formation of foamy macrophages and reducing cellular uptake of...
Conference Coverage
New drugs in primary care: Lessons learned from COVID-19
Nirmatrelvir-ritonavir has helped keep many patients out of the hospital, says internist.
From the Journals
Tyrosine kinase inhibitors – a new weapon against respiratory viruses?
In vitro and ex vivo data demonstrated NRTKIs’ ability to slow replication of pandemic and seasonal influenza strains
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
Feature
NOVIDs: Do some have the genes to dodge COVID?
Some in the U.S. have apparently managed to avoid the virus, data suggest.
From the Journals
Factors linked with increased VTE risk in COVID outpatients
While the overall risk for VTE was low, age of at least 55 years, being male, and having a BMI of at least 30 and history of VTE increased the...
Latest News
Are early childhood viral infections linked with asthma?
Globally, 28% of children infected by either rhinovirus of RSV were deemed to have asthma at 6 years of age.
Feature
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
News
Even mild COVID is hard on the brain
New study results suggest a severe pattern of changes in how the brain communicates as well as its structure in people with anxiety and depression...